Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 1, 2026 16:48 UTC |
PRICHEP PATRICIA BChief Financial Officer
|
GrantCommon Stock | 2,082 | $2.06 | $4,288.92 |
DisclosureSEC source: 0001236215-26-000005 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,571 Read SEC document |
| September 30, 2026 Filed Oct 1, 2026 16:44 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantCommon Stock | 2,621 | $2.06 | $5,399.26 |
DisclosureSEC source: 0001236030-26-000009 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,763 Read SEC document |
| September 30, 2026 Filed Oct 1, 2026 16:51 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 1,165 | $2.06 | $2,399.90 |
DisclosureSEC source: 0001238028-26-000005 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,483 Read SEC document |
| August 25, 2026 Filed Aug 26, 2026 12:32 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 100,000 | $1.38 | $138,000.00 |
DisclosureSEC source: 0001236030-26-000008 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,142 F1 · shares: On August 25, 2026, Mr. Kersten purchased 100,000 shares of restricted stock directly from the Company at the closing price on August 24, 2026, the most recent closing price available. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 13:43 UTC |
Watson Robert EugeneDirector
|
GrantOptions · Derivative | 110,000 | $0.01 Strike: $1.49 | $1,100.00 |
DisclosureSEC source: 0001511858-26-000001 · primary_doc.xml · derivative · entry 1 Watson Robert Eugene · CIK 0001511858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,271 Underlying: Common Stock · 110,000 shares Expires 2036-08-13 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 13:37 UTC |
BAILLAVOINE BRUNO JEAN-MARIEDirector
|
GrantOptions · Derivative | 110,000 | $0.01 Strike: $1.49 | $1,100.00 |
DisclosureSEC source: 0001646989-26-000001 · primary_doc.xml · derivative · entry 1 BAILLAVOINE BRUNO JEAN-MARIE · CIK 0001646989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,021 Underlying: Common Stock · 110,000 shares Expires 2036-08-13 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 13:33 UTC |
CIPRIANO JOHNSenior Vice President
|
GrantOptions · Derivative | 80,000 | $0.01 Strike: $1.49 | $800.00 |
DisclosureSEC source: 0001282304-26-000001 · primary_doc.xml · derivative · entry 1 CIPRIANO JOHN · CIK 0001282304 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,010 Underlying: Common Stock · 80,000 shares Expires 2036-08-13 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 13:27 UTC |
TALOR EYALChief Scientific Officer
|
GrantOptions · Derivative | 250,000 | $0.01 Strike: $1.49 | $2,500.00 |
DisclosureSEC source: 0001238028-26-000004 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,625 Underlying: Common Stock · 250,000 shares Expires 2036-08-13 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 13:23 UTC |
PRICHEP PATRICIA BChief Financial Officer
|
GrantOptions · Derivative | 225,000 | $0.01 Strike: $1.49 | $2,250.00 |
DisclosureSEC source: 0001236215-26-000004 · primary_doc.xml · derivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,693 Underlying: Common Stock · 225,000 shares Expires 2036-08-13 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 13:19 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantOptions · Derivative | 300,000 | $0.01 Strike: $1.49 | $3,000.00 |
DisclosureSEC source: 0001236030-26-000007 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 452,380 Underlying: Common Stock · 300,000 shares Expires 2036-08-13 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 12:37 UTC |
PRICHEP PATRICIA BChief Financial Officer
|
GrantCommon Stock | 4,125 | $1.04 | $4,290.00 |
DisclosureSEC source: 0001236215-26-000003 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,489 Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 12:40 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 2,307 | $1.04 | $2,399.28 |
DisclosureSEC source: 0001238028-26-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,318 Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 12:33 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantCommon Stock | 5,192 | $1.04 | $5,399.68 |
DisclosureSEC source: 0001236030-26-000006 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,142 Read SEC document |
| May 14, 2026 Filed May 18, 2026 12:03 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 300,000 | $1.20 | $360,000.00 |
DisclosureSEC source: 0001236030-26-000005 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Trustee Disclosed balance after: 311,547 F1 · shares: On May 14, 2026, the de Clara Trust, of which Mr. Kersten is a trustee, purchased 300,000 shares of restricted stock directly from the Company at the closing price on May 13, 2026, the most recent closing price available. Read SEC document |
| May 13, 2026 Filed May 14, 2026 12:56 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 100,000 | $1.19 | $119,000.00 |
DisclosureSEC source: 0001236030-26-000004 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,497 F1 · shares: On May 13, 2026, Mr. Kersten purchased 100,000 shares of restricted stock directly from the Company at the closing price on May 12, 2026, the most recent closing price available. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 11:03 UTC |
PRICHEP PATRICIA BChief Financial Officer
|
GrantCommon Stock | 1,336 | $3.21 | $4,288.56 |
DisclosureSEC source: 0001236215-26-000002 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,364 Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 10:59 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantCommon Stock | 1,682 | $3.21 | $5,399.22 |
DisclosureSEC source: 0001236030-26-000003 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,497 Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 11:08 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 747 | $3.21 | $2,397.87 |
DisclosureSEC source: 0001238028-26-000002 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,011 Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 13:23 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 38,023 | $5.26 | $200,000.98 |
DisclosureSEC source: 0001236030-26-000002 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,815 F1 · shares: On January 22, 2026, Mr. Kersten purchased 38,023 shares of restricted stock directly from the Company at the closing price on January 21, 2026, the most recent closing price available. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 14:30 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 456 | $5.26 | $2,398.56 |
DisclosureSEC source: 0001238028-26-000001 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,264 Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 14:26 UTC |
PRICHEP PATRICIA BChief Financial Officer
|
GrantCommon Stock | 815 | $5.26 | $4,286.90 |
DisclosureSEC source: 0001236215-26-000001 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,028 Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 14:23 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantCommon Stock | 998 | $5.26 | $5,249.48 |
DisclosureSEC source: 0001236030-26-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,792 Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 13:48 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 8,389 | $5.96 | $49,998.44 |
DisclosureSEC source: 0001236030-25-000019 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,794 F1 · shares: On December 4, 2025, Mr. Kersten purchased 8,389 shares of restricted stock directly from the Company at the closing price on December 3, 2025, the most recent closing price available. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:01 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 260 | $9.20 | $2,392.00 |
DisclosureSEC source: 0001238028-25-000002 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,808 Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 19:57 UTC |
PRICHEP PATRICIA BChief Financial Officer
|
GrantCommon Stock | 466 | $9.20 | $4,287.20 |
DisclosureSEC source: 0001236215-25-000005 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,213 Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 19:46 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantCommon Stock | 570 | $9.20 | $5,244.00 |
DisclosureSEC source: 0001236030-25-000016 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,405 Read SEC document |
| July 28, 2025 Filed Jul 29, 2025 21:20 UTC |
Watson Robert EugeneDirector
|
GrantOptions · Derivative | 4,000 | $0.01 Strike: $8.20 | $40.00 |
DisclosureSEC source: 0001236030-25-000014 · primary_doc.xml · derivative · entry 1 Watson Robert Eugene · CIK 0001511858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,266 Underlying: Common Stock · 4,000 shares Expires 2035-07-27 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| July 28, 2025 Filed Jul 29, 2025 21:15 UTC |
BAILLAVOINE BRUNO JEAN-MARIEDirector
|
GrantOptions · Derivative | 4,000 | $0.01 Strike: $8.20 | $40.00 |
DisclosureSEC source: 0001236030-25-000013 · primary_doc.xml · derivative · entry 1 BAILLAVOINE BRUNO JEAN-MARIE · CIK 0001646989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,017 Underlying: Common Stock · 4,000 shares Expires 2035-07-27 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| July 28, 2025 Filed Jul 29, 2025 21:12 UTC |
CIPRIANO JOHNSenior Vice President
|
GrantOptions · Derivative | 7,500 | $0.01 Strike: $8.20 | $75.00 |
DisclosureSEC source: 0001236030-25-000012 · primary_doc.xml · derivative · entry 1 CIPRIANO JOHN · CIK 0001282304 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,008 Underlying: Common Stock · 7,500 shares Expires 2035-07-27 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| July 28, 2025 Filed Jul 29, 2025 21:05 UTC |
TALOR EYALChief Scientific Officer
|
GrantOptions · Derivative | 15,000 | $0.01 Strike: $8.20 | $150.00 |
DisclosureSEC source: 0001236030-25-000011 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,622 Underlying: Common Stock · 15,000 shares Expires 2035-07-27 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| July 28, 2025 Filed Jul 29, 2025 21:00 UTC |
PRICHEP PATRICIA BChief Financial Officer
|
GrantOptions · Derivative | 12,000 | $0.01 Strike: $8.20 | $120.00 |
DisclosureSEC source: 0001236030-25-000010 · primary_doc.xml · derivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,127 Underlying: Common Stock · 12,000 shares Expires 2035-07-27 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| July 28, 2025 Filed Jul 29, 2025 20:55 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantOptions · Derivative | 25,000 | $0.01 Strike: $8.20 | $250.00 |
DisclosureSEC source: 0001236030-25-000009 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,157 Underlying: Common Stock · 25,000 shares Expires 2035-07-27 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 13:36 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 29,197 | $6.85 | $199,999.45 |
DisclosureSEC source: 0001236030-25-000007 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,835 F1 · shares: On July 25, 2025, Mr. Kersten purchased 29,197 shares of restricted stock directly from the Company at the closing price on July 24, 2025, the most recent closing price available. Read SEC document |
| July 25, 2025 Filed Jul 29, 2025 11:56 UTC |
Watson Robert EugeneDirector
|
PurchaseCommon Stock | 2,919 | $6.85 | $19,995.15 |
DisclosureSEC source: 0001236030-25-000008 · primary_doc.xml · nonDerivative · entry 1 Watson Robert Eugene · CIK 0001511858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,733 F1 · shares: On July 25, 2025, Mr. Watson purchased 2,919 shares of restricted stock directly from the Company at the closing price on July 24, 2025, the most recent closing price available. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 13:29 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 1,048 | $2.29 | $2,399.92 |
DisclosureSEC source: 0001236030-25-000006 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,548 Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 13:26 UTC |
PRICHEP PATRICIA BChief Financial Officer
|
GrantCommon Stock | 1,873 | $2.29 | $4,289.17 |
DisclosureSEC source: 0001236030-25-000005 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,747 Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 13:22 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantCommon Stock | 2,292 | $2.29 | $5,248.68 |
DisclosureSEC source: 0001236030-25-000004 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,638 Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 13:51 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 10,416 | $0.23 | $2,399.85 |
DisclosureSEC source: 0001236030-25-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,013 Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 13:49 UTC |
PRICHEP PATRICIA BChief Financial Officer
|
GrantCommon Stock | 15,432 | $0.23 | $3,555.53 |
DisclosureSEC source: 0001236030-25-000002 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 266,230 Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 13:46 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantCommon Stock | 22,786 | $0.23 | $5,249.89 |
DisclosureSEC source: 0001236030-25-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,240,378 Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 19:25 UTC |
KERSTEN GEERT RDirector · CEO
|
GrantCommon Stock | 12,940 | $0.40 | $5,176.00 |
DisclosureSEC source: 0001236215-25-000003 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,217,592 Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 19:18 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 6,001 | $0.40 | $2,400.40 |
DisclosureSEC source: 0001236215-25-000002 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,597 Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 19:12 UTC |
PRICHEP PATRICIA BChief Financial & Operations
|
GrantCommon Stock | 10,727 | $0.40 | $4,290.80 |
DisclosureSEC source: 0001236215-25-000001 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Chief Financial & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,798 Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 13:13 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 2,264 | $1.06 | $2,399.84 |
DisclosureSEC source: 0001236215-24-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,596 Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 13:05 UTC |
PRICHEP PATRICIA BSr. VP of Operations
|
GrantCommon Stock | 4,047 | $1.06 | $4,289.82 |
DisclosureSEC source: 0001236215-24-000002 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Sr. VP of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,071 Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 12:58 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantCommon Stock | 4,882 | $1.06 | $5,174.92 |
DisclosureSEC source: 0001236215-24-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,204,652 Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 13:16 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 2,068 | $1.16 | $2,398.88 |
DisclosureSEC source: 0001236030-24-000018 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,332 Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 13:14 UTC |
PRICHEP PATRICIA BSenior Vice President
|
GrantCommon Stock | 3,698 | $1.16 | $4,289.68 |
DisclosureSEC source: 0001236030-24-000017 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,024 Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 13:10 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantCommon Stock | 4,461 | $1.16 | $5,174.76 |
DisclosureSEC source: 0001236030-24-000016 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,199,770 Read SEC document |
| May 08, 2024 Filed May 9, 2024 17:07 UTC |
PRICHEP PATRICIA BSenior Vice President
|
PurchaseCommon Stock | 8,000 | $1.39 | $11,120.00 |
DisclosureSEC source: 0001236030-24-000014 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,326 F1 · shares: On May 8, 2024, Ms. Prichep purchased 8,000 shares of restricted stock directly from the Company at the closing price on May 8, 2024, the most recent closing price available. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.